Medical device recalls Moderate risk

DiaSorin Molecular LLC recalls SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051

Recall date
September 23, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0162-2022
FDA classification
Class II
Brand / firm
DiaSorin Molecular LLC
Sold / distributed
Worldwide distribution - US Nationwide distribution in the states of AL, AZ, CA, CO, DE, FL, GA, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, NC, ND, NE, NJ, NV, NY, OH, OK, PA, SD, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Italy.

Why it was recalled

Due to unapproved raw materials used in the manufacturing of Covid-19 control pack, their is the potential for delayed amplification signals.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051

Get recall alerts

Free email alert whenever DiaSorin Molecular LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: DiaSorin Molecular LLC